Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency

H. S. Al-Rimawi, M. Al-Sheyyab, A. Batieha, H. El-Shanti, F. Abuekteish

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effectiveness of desferrioxamine (DFO) in ameliorating the severity of the acute haemolysis of glucose-6-phosphate dehydrogenase (G6PD) deficiency was studied in 167 children with G6PD deficiency during an acute haemolytic crisis. All patients received packed cell transfusion on admission if their Hb levels were < 8 g/dl, which was repeated as needed. Eighty patients also received a single dose of DFO 30-40 mg/kg by slow intravenous infusion (DFO group). The remaining 87 children did not receive DFO (control group). The need for more than one transfusion was less frequent in the DFO group as compared to the control group (p = 0.01). The need for late transfusion (transfusion after 36 h of admission) was also less in the DFO group (7%) compared to 21% in the control group (p = 0.02). On average, children in the DFO group needed less packed red blood cells (16.5 ml/kg body weight) than the control group (22.8 ml/kg body weight) and the difference was highly significant (p = 0.0001). We conclude from this study that DFO in a small dose is effective in the treatment of acute haemolytic crises of G6PD deficiency. It shortens the duration of the crisis and decreases the amount of blood transfusion needed.

Original languageEnglish
Pages (from-to)145-148
Number of pages4
JournalActa Haematologica
Volume101
Issue number3
DOIs
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Glucosephosphate Dehydrogenase Deficiency
Deferoxamine
Hemolytic Anemia
Control Groups
Body Weight
Hemolysis
Intravenous Infusions
Blood Transfusion
Erythrocytes

Keywords

  • Acute haemolytic anaemia
  • Desferrioxamine
  • Favism
  • Glucose-6-phosphate dehydrogenase deficiency

ASJC Scopus subject areas

  • Hematology

Cite this

Al-Rimawi, H. S., Al-Sheyyab, M., Batieha, A., El-Shanti, H., & Abuekteish, F. (1999). Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency. Acta Haematologica, 101(3), 145-148. https://doi.org/10.1159/000040941

Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency. / Al-Rimawi, H. S.; Al-Sheyyab, M.; Batieha, A.; El-Shanti, H.; Abuekteish, F.

In: Acta Haematologica, Vol. 101, No. 3, 1999, p. 145-148.

Research output: Contribution to journalArticle

Al-Rimawi, HS, Al-Sheyyab, M, Batieha, A, El-Shanti, H & Abuekteish, F 1999, 'Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency', Acta Haematologica, vol. 101, no. 3, pp. 145-148. https://doi.org/10.1159/000040941
Al-Rimawi, H. S. ; Al-Sheyyab, M. ; Batieha, A. ; El-Shanti, H. ; Abuekteish, F. / Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency. In: Acta Haematologica. 1999 ; Vol. 101, No. 3. pp. 145-148.
@article{0e1dd0f2aa114415b803c7a1650557fb,
title = "Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency",
abstract = "The effectiveness of desferrioxamine (DFO) in ameliorating the severity of the acute haemolysis of glucose-6-phosphate dehydrogenase (G6PD) deficiency was studied in 167 children with G6PD deficiency during an acute haemolytic crisis. All patients received packed cell transfusion on admission if their Hb levels were < 8 g/dl, which was repeated as needed. Eighty patients also received a single dose of DFO 30-40 mg/kg by slow intravenous infusion (DFO group). The remaining 87 children did not receive DFO (control group). The need for more than one transfusion was less frequent in the DFO group as compared to the control group (p = 0.01). The need for late transfusion (transfusion after 36 h of admission) was also less in the DFO group (7{\%}) compared to 21{\%} in the control group (p = 0.02). On average, children in the DFO group needed less packed red blood cells (16.5 ml/kg body weight) than the control group (22.8 ml/kg body weight) and the difference was highly significant (p = 0.0001). We conclude from this study that DFO in a small dose is effective in the treatment of acute haemolytic crises of G6PD deficiency. It shortens the duration of the crisis and decreases the amount of blood transfusion needed.",
keywords = "Acute haemolytic anaemia, Desferrioxamine, Favism, Glucose-6-phosphate dehydrogenase deficiency",
author = "Al-Rimawi, {H. S.} and M. Al-Sheyyab and A. Batieha and H. El-Shanti and F. Abuekteish",
year = "1999",
doi = "10.1159/000040941",
language = "English",
volume = "101",
pages = "145--148",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency

AU - Al-Rimawi, H. S.

AU - Al-Sheyyab, M.

AU - Batieha, A.

AU - El-Shanti, H.

AU - Abuekteish, F.

PY - 1999

Y1 - 1999

N2 - The effectiveness of desferrioxamine (DFO) in ameliorating the severity of the acute haemolysis of glucose-6-phosphate dehydrogenase (G6PD) deficiency was studied in 167 children with G6PD deficiency during an acute haemolytic crisis. All patients received packed cell transfusion on admission if their Hb levels were < 8 g/dl, which was repeated as needed. Eighty patients also received a single dose of DFO 30-40 mg/kg by slow intravenous infusion (DFO group). The remaining 87 children did not receive DFO (control group). The need for more than one transfusion was less frequent in the DFO group as compared to the control group (p = 0.01). The need for late transfusion (transfusion after 36 h of admission) was also less in the DFO group (7%) compared to 21% in the control group (p = 0.02). On average, children in the DFO group needed less packed red blood cells (16.5 ml/kg body weight) than the control group (22.8 ml/kg body weight) and the difference was highly significant (p = 0.0001). We conclude from this study that DFO in a small dose is effective in the treatment of acute haemolytic crises of G6PD deficiency. It shortens the duration of the crisis and decreases the amount of blood transfusion needed.

AB - The effectiveness of desferrioxamine (DFO) in ameliorating the severity of the acute haemolysis of glucose-6-phosphate dehydrogenase (G6PD) deficiency was studied in 167 children with G6PD deficiency during an acute haemolytic crisis. All patients received packed cell transfusion on admission if their Hb levels were < 8 g/dl, which was repeated as needed. Eighty patients also received a single dose of DFO 30-40 mg/kg by slow intravenous infusion (DFO group). The remaining 87 children did not receive DFO (control group). The need for more than one transfusion was less frequent in the DFO group as compared to the control group (p = 0.01). The need for late transfusion (transfusion after 36 h of admission) was also less in the DFO group (7%) compared to 21% in the control group (p = 0.02). On average, children in the DFO group needed less packed red blood cells (16.5 ml/kg body weight) than the control group (22.8 ml/kg body weight) and the difference was highly significant (p = 0.0001). We conclude from this study that DFO in a small dose is effective in the treatment of acute haemolytic crises of G6PD deficiency. It shortens the duration of the crisis and decreases the amount of blood transfusion needed.

KW - Acute haemolytic anaemia

KW - Desferrioxamine

KW - Favism

KW - Glucose-6-phosphate dehydrogenase deficiency

UR - http://www.scopus.com/inward/record.url?scp=0033019356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033019356&partnerID=8YFLogxK

U2 - 10.1159/000040941

DO - 10.1159/000040941

M3 - Article

VL - 101

SP - 145

EP - 148

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 3

ER -